Rexulti was the first medicine approved by the FDA for reducing symptoms of agitation in dementia due to Alzheimer’s disease. Rexulti is a third-generation antipsychotic medicine that works ...

Rexulti (brexpiprazole) is a prescription drug that’s used to treat depression and other conditions related to mental health. Rexulti can cause side effects that range from mild to serious ...

The price you pay for Rexulti may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the ...

The newer second-generation antipsychotics, like Rexulti (brexpiprazole), block chemicals in the brain in a different way to help improve symptoms but also reduce the risk of side effects.

The FDA will hold a joint meeting of its expert advisors to determine whether the drug Rexulti (brexpiprazole) is appropriate for use in treating agitation associated with Alzheimer’s disease ...

Approval makes Rexulti the lone treatment approved for agitation associated with Alzheimer’s dementia. Two FDA committees ruled in April that Rexulti’s benefits outweighed risks. The FDA has ...

May 11 (UPI) --The Food and Drug Administration on Thursday announced the supplemental approval of Alzheimer's disease drug Rexulti, which treats agitation. Rexulti is an oral tablet that treats ...

NEW ORLEANS -- Brexpiprazole (Rexulti) helped ease agitation in people with Alzheimer's dementia, according to a phase III study. Over the course of the 12-week trial, patients on either a 2-mg or ...

After Lundbeck and Otsuka’s Rexulti cleared a key advisory committee hurdle, the FDA has given the drug the go-ahead to treat dementia-associated agitation in Alzheimer’s disease patients With ...

Rexulti (brexpiprazole) is a brand-name oral tablet that’s prescribed for certain mental health conditions. Rexulti has interactions with alcohol, some other drugs, and certain supplements ...